UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000026498
Receipt number R000030430
Scientific Title Evaluation of efficacy and safety of a response adapted therapy adding bortezomib in newly diagnosed, transplant ineligible multiple myeloma patients with insufficient efficacy by lenalidomide - dexamethasone (Rd) therapy.
Date of disclosure of the study information 2017/03/10
Last modified on 2021/03/13 16:01:47

No. Disposal Last modified on Item of update
1 Insert 2017/03/10 13:11:51
2 Update 2017/06/02 11:51:53 Recruitment status
Date of protocol fixation
Anticipated trial start date
3 Update 2019/09/11 11:02:06 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
4 Update 2021/03/13 16:01:47 Recruitment status
Date of IRB
Last follow-up date